t2biosystems.com - TTOO Total Company Value-to-Revenue Ratio

T2 Biosystems Inc. (TTOO) - corporate logo

The EV/Sales trend demonstrates the market value of T2 Biosystems, Inc. (TTOO) relative to its revenues, with the indicator reaching . T2 Biosystems, Inc. (TTOO) develops rapid detection systems for sepsis in hospitals to reduce infection-related mortality. Competition with laboratory behemoths for clinic budgets complicates growth; however, patents for MRI diagnostics provide a technological edge despite vulnerable sales margins.

T2 Biosystems, Inc (TTOO) EV/Sales Multiple: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for T2 Biosystems, Inc (TTOO)

- share price and consensus valuation forecast:
Fundamental company valuation:TTOO, t2biosystems.com
Flagship merchandise of T2 Biosystems Inc.

The EV/Sales multiple measures the total value of a business, including net debt, relative to generated revenue, allowing for an assessment of the real value of assets without distortions from debt load. By analyzing changes in the EV/Sales multiple, an investor can compare the current sales of T2 Biosystems, Inc. (TTOO) diagnostic systems with market expectations for future defense contracts to determine the degree of the company's overvaluation.